Last reviewed · How we verify

Control tetanus vaccine, adsorbed — Competitive Intelligence Brief

Control tetanus vaccine, adsorbed (Control tetanus vaccine, adsorbed) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated bacterial toxoid vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated bacterial toxoid vaccine Tetanus toxin (tetanospasmin) Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Control tetanus vaccine, adsorbed (Control tetanus vaccine, adsorbed) — Sinovac Life Sciences Co., Ltd.. This vaccine stimulates the immune system to produce antibodies against tetanus toxin by presenting inactivated tetanus toxoid adsorbed onto an aluminum salt adjuvant.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Control tetanus vaccine, adsorbed TARGET Control tetanus vaccine, adsorbed Sinovac Life Sciences Co., Ltd. phase 3 Inactivated bacterial toxoid vaccine Tetanus toxin (tetanospasmin)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated bacterial toxoid vaccine class)

  1. Sinovac Life Sciences Co., Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Control tetanus vaccine, adsorbed — Competitive Intelligence Brief. https://druglandscape.com/ci/control-tetanus-vaccine-adsorbed. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: